Sarah R Powell is a Senior Signatory at PharmaReview Ltd., where Sarah R serves as the final medical signatory and medical lead for oncology EAMS and ILAP/TDP programmes. With a background in pharmacy and extensive experience in the pharmaceutical industry, Sarah has held various senior positions at companies like Boyd Powell Ltd., Bristol Myers Squibb, and Celgene. Throughout their career, Sarah R has demonstrated expertise in medical affairs, oncology, and rare diseases, contributing significantly to the success of multiple myeloma assets, projects, and educational activities.
May, 2023 - present